Satpathy Chhabi, Mishra Trinath K, Satpathy Ruby, Satpathy Hemant K, Barone Eugene
Department of Cardiology, Utkal University, Sriram Chandra Bhanja Medical College, Cuttack, Orissa, India.
Am Fam Physician. 2006 Mar 1;73(5):841-6.
Diastolic heart failure occurs when signs and symptoms of heart failure are present but left ventricular systolic function is preserved (i.e., ejection fraction greater than 45 percent). The incidence of diastolic heart failure increases with age; therefore, 50 percent of older patients with heart failure may have isolated diastolic dysfunction. With early diagnosis and proper management the prognosis of diastolic dysfunction is more favorable than that of systolic dysfunction. Distinguishing diastolic from systolic heart failure is essential because the optimal therapy for one may aggravate the other. Although diastolic heart failure is clinically and radiographically indistinguishable from systolic heart failure, normal ejection fraction and abnormal diastolic function in the presence of symptoms and signs of heart failure confirm diastolic heart failure. The pharmacologic therapies of choice for diastolic heart failure are angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, diuretics, and beta blockers.
当存在心力衰竭的体征和症状,但左心室收缩功能保留(即射血分数大于45%)时,即发生舒张性心力衰竭。舒张性心力衰竭的发病率随年龄增长而增加;因此,50%的老年心力衰竭患者可能存在孤立性舒张功能障碍。通过早期诊断和适当管理,舒张功能障碍的预后比收缩功能障碍更有利。区分舒张性心力衰竭和收缩性心力衰竭至关重要,因为针对其中一种的最佳治疗可能会加重另一种。尽管舒张性心力衰竭在临床和影像学上与收缩性心力衰竭无法区分,但在存在心力衰竭的症状和体征时,正常射血分数和异常舒张功能可确诊舒张性心力衰竭。舒张性心力衰竭的首选药物治疗是血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂、利尿剂和β受体阻滞剂。